Dynavax Net Income from 2010 to 2024

DVAX Stock  USD 12.41  0.04  0.32%   
Dynavax Technologies Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss will likely drop to about -6.7 M in 2024. During the period from 2010 to 2024, Dynavax Technologies Net Loss regression line of annual values had significance of  0.16 and arithmetic mean of (44,160,297). View All Fundamentals
 
Net Loss  
First Reported
2001-12-31
Previous Quarter
14.3 M
Current Value
219 K
Quarterly Volatility
27 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dynavax Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dynavax main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.1 M, Interest Expense of 4 M or Other Operating Expenses of 270.9 M, as well as many exotic indicators such as Short Term Coverage Ratios of 23.49, Price To Sales Ratio of 7.36 or Dividend Yield of 0.0. Dynavax financial statements analysis is a perfect complement when working with Dynavax Technologies Valuation or Volatility modules.
  
This module can also supplement Dynavax Technologies' financial leverage analysis and stock options assessment as well as various Dynavax Technologies Technical models . Check out the analysis of Dynavax Technologies Correlation against competitors.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Latest Dynavax Technologies' Net Income Growth Pattern

Below is the plot of the Net Income of Dynavax Technologies over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Dynavax Technologies financial statement analysis. It represents the amount of money remaining after all of Dynavax Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Dynavax Technologies' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dynavax Technologies' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (6.39 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Dynavax Net Income Regression Statistics

Arithmetic Mean(44,160,297)
Coefficient Of Variation(251.73)
Mean Deviation73,446,538
Median(69,949,000)
Standard Deviation111,164,481
Sample Variance12357.5T
Range452.1M
R-Value0.38
Mean Square Error11387.9T
R-Squared0.14
Significance0.16
Slope9,442,110
Total Sum of Squares173005.6T

Dynavax Net Income History

2024-6.7 M
2023-6.4 M
2022293.2 M
202176.7 M
2020-91.8 M
2019-151.4 M
2018-158.9 M

Other Fundumenentals of Dynavax Technologies

About Dynavax Technologies Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Dynavax Technologies income statement, its balance sheet, and the statement of cash flows. Dynavax Technologies investors use historical funamental indicators, such as Dynavax Technologies's Net Income, to determine how well the company is positioned to perform in the future. Although Dynavax Technologies investors may use each financial statement separately, they are all related. The changes in Dynavax Technologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Dynavax Technologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Dynavax Technologies Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Dynavax Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Net Loss-6.4 M-6.7 M
Net Income From Continuing Ops61.1 M64.2 M
Net Income Applicable To Common Shares336.8 M353.6 M
Net Income Per E B T 1.46  0.88 

Pair Trading with Dynavax Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dynavax Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will appreciate offsetting losses from the drop in the long position's value.

Moving together with Dynavax Stock

  0.66MBRX Moleculin Biotech Financial Report 9th of May 2024 PairCorr
  0.83MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Dynavax Stock

  0.88DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.8EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.78MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.7MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.63MDWD Mediwound Downward RallyPairCorr
The ability to find closely correlated positions to Dynavax Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dynavax Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dynavax Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dynavax Technologies to buy it.
The correlation of Dynavax Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dynavax Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dynavax Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dynavax Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Dynavax Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dynavax Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dynavax Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dynavax Technologies Stock:
Check out the analysis of Dynavax Technologies Correlation against competitors.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.
Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Dynavax Stock analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Is Dynavax Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dynavax Technologies. If investors know Dynavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dynavax Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Earnings Share
(0.05)
Revenue Per Share
1.804
Quarterly Revenue Growth
(0.70)
Return On Assets
(0.02)
The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dynavax Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.